# OpAns, LLC – FDA Inspection, Jan 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/opans-llc/ba87504e-ad51-4226-8c87-67c0d337ef87
Source feed: FDA_Inspections

> FDA inspection 1230774 of OpAns, LLC, January 24, 2024. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230774
- Company Name: OpAns, LLC
- Inspection Date: 2024-01-24
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1125999 - 2020-01-24](https://www.keypedia.com/records/fda_inspections/opans-llc/d9ac4d6d-0ad0-4fc2-865b-afcfd6f0aba6)
- [FDA Inspection 1102873 - 2019-08-16](https://www.keypedia.com/records/fda_inspections/opans-llc/ffc11075-1841-44fb-a1e4-8350073d633b)
- [FDA Inspection 937288 - 2015-08-03](https://www.keypedia.com/records/fda_inspections/opans-llc/1965dc96-3a94-4c7d-bdf0-9e36685e5073)
- FDA Inspection 547289 - 2008-11-18

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/betsy-c-galliher/04add63c-cbcb-42f7-b634-7c2925600bef)
- [Issuing Officer](https://www.keypedia.com/people/hasan-a-irier/8757c2d5-77b0-45a7-b0f2-e42ef3ee306f)
- Issuing Officer

Company: https://www.keypedia.com/companies/opans-llc/dc176b50-d60c-4ef5-b29f-7dcb8231f974

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c